Medication Adherence Monitoring at the Point of Care: Pediatric Asthma as a Test Case
护理点药物依从性监测:小儿哮喘作为测试案例
基本信息
- 批准号:9895965
- 负责人:
- 金额:$ 3.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract
Recent technological advances have brought pharmacy dispensing data to the bedside in near real time for a
large number of practicing providers. Ready access to patients' pharmacy dispensing data has the potential to
transform the way we monitor medication adherence and how we react to this information. Because this
technology is relatively new, providers have yet to design systematic approaches to incorporating these data
into their clinical practice. Children with asthma are among those most likely to benefit from proactive
monitoring of prescription dispensing data because of the availability of effective controller medications,
historically poor adherence, and costly yet preventable exacerbations. Additionally, the asthma medication
ratio (AMR) (# of controller medication fills/(# of controller fills +# of rescue fills)) is a pharmacy claims based
asthma risk predictor that identifies children at high risk for subsequent exacerbation. The AMR has been used
as a quality of care metric but has not been translated into a bedside risk prediction tool, owing in part to the
previous lack of available, timely pharmacy dispensing data. Pharmacy dispensing reports available through
Surescripts have increased the likelihood that the AMR could be successfully translated into a bedside risk
prediction tool. This proactive approach could ultimately prevent costly ED visits and hospitalizations for
asthma. In order for a risk predictor to be utilized as a population management or bedside risk prediction tool, it
must be precise (based on accurate data and with optimized sensitivity and specificity), convenient (readily
available to clinicians at the point of care, measureable on large populations of children), and timely
(determined using the most proximal and fewest number of data points possible). Surescripts has improved the
convenience and timeliness of this potentially effective risk prediction tool but before it can be used at the
bedside we must determine its precision. First we must determine and compare the precision of the AMR
against previously utilized risk prediction tools. Additionally, we must examine the accuracy of the pharmacy
dispensing data available in Surescripts by comparing it to the gold standard of payer supplied claims data. By
attempting to independently verify the accuracy and completeness of bedside dispensing data and determining
if the AMR is the most accurate asthma risk predictor available we will take an important step towards
developing a systematic approach for using pharmacy dispensing data to improve patient care.
项目摘要/摘要
最近的技术进步将药房配药数据近乎实时地带到了床边,以便
大量的执业提供者。随时访问患者的药房配药数据可能会
改变我们监测用药依从性的方式以及我们对这些信息的反应方式。因为这件事
技术相对较新,供应商还没有设计出系统的方法来整合这些数据
进入他们的临床实践。哮喘儿童是最有可能从积极主动中受益的人之一。
由于有效的控制者药物的可用性,对处方分配数据的监测,
从历史上看,遵守情况很差,而且代价高昂但可以预防的恶化。另外,哮喘药物
比率(AMR)(控制器药物填充的数量/(控制器填充的数量+救援填充的数量))是基于药房索赔的
哮喘风险预报器,可识别高危儿童的后续病情恶化。已使用AMR
作为护理质量指标,但尚未转化为床边风险预测工具,部分原因是
以前缺乏可用的、及时的药房配药数据。药房配药报告可通过
提交文件增加了AMR成功转化为床边风险的可能性
预测工具。这种积极主动的方法最终可以防止昂贵的急诊室就诊和住院治疗
哮喘。为了将风险预测器用作人口管理或床边风险预测工具,它
必须准确(基于准确的数据并具有优化的灵敏度和特异度)、方便(容易
在护理点向临床医生提供,可在大量儿童人口中衡量),并及时
(使用尽可能最接近和最少的数据点来确定)。Surescript改进了
这一潜在有效的风险预测工具的便利性和及时性,但在它可以在
在床边,我们必须确定它的精度。首先,我们必须确定和比较AMR的精度
对照以前使用的风险预测工具。此外,我们还必须检查药房的准确性
通过将Surescript中可用的数据与付款人提供的索赔数据的黄金标准进行比较来分发数据。通过
尝试独立验证床边配药数据的准确性和完整性并确定
如果AMR是可用的最准确的哮喘风险预测指标,我们将迈出重要的一步
开发一种系统的方法,使用药房配药数据来改善患者护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anne L Andrews其他文献
Anne L Andrews的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anne L Andrews', 18)}}的其他基金
Medication Adherence Monitoring at the Point of Care: Pediatric Asthma as a Test Case
护理点药物依从性监测:小儿哮喘作为测试案例
- 批准号:
10005343 - 财政年份:2019
- 资助金额:
$ 3.72万 - 项目类别:
相似海外基金
Point-of-Care Electrochemical Aptasensor for Long-Term Pharmacological Adherence Monitoring
用于长期药理学依从性监测的护理点电化学适体传感器
- 批准号:
10927085 - 财政年份:2023
- 资助金额:
$ 3.72万 - 项目类别:
Developing a culturally tailored mHealth symptom monitoring intervention to improve adherence to endocrine therapy among Black women with breast cancer
开发适合文化的移动健康症状监测干预措施,以提高患有乳腺癌的黑人女性对内分泌治疗的依从性
- 批准号:
10642274 - 财政年份:2023
- 资助金额:
$ 3.72万 - 项目类别:
Point-of-Care Monitoring of Adherence to Antiretroviral HIV Therapy
抗逆转录病毒 HIV 治疗依从性的护理点监测
- 批准号:
10927081 - 财政年份:2023
- 资助金额:
$ 3.72万 - 项目类别:
Feasibility, acceptability, and pilot trial of a real-time electronic adherence monitoring intervention for antiretroviral therapy
抗逆转录病毒治疗实时电子依从性监测干预措施的可行性、可接受性和试点试验
- 批准号:
10759928 - 财政年份:2023
- 资助金额:
$ 3.72万 - 项目类别:
Fast and accurate self-monitoring tests for better adherence to exercise and diet
快速准确的自我监测测试,以更好地坚持运动和饮食
- 批准号:
10046930 - 财政年份:2022
- 资助金额:
$ 3.72万 - 项目类别:
Grant for R&D
A novel algorithm to compute adherence from electronic adherence monitoring devices
一种计算电子依从性监测设备依从性的新算法
- 批准号:
10698066 - 财政年份:2022
- 资助金额:
$ 3.72万 - 项目类别:
A novel algorithm to compute adherence from electronic adherence monitoring devices
一种计算电子依从性监测设备依从性的新算法
- 批准号:
10516828 - 财政年份:2022
- 资助金额:
$ 3.72万 - 项目类别:
iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities
iGLAMOUR 研究:青光眼依从性和监测代表性不足的少数群体的创新
- 批准号:
10549804 - 财政年份:2021
- 资助金额:
$ 3.72万 - 项目类别:
Rapid Point of Care Test to Quantify HIV Drugs for Adherence Monitoring
用于量化 HIV 药物以进行依从性监测的快速护理测试
- 批准号:
10439549 - 财政年份:2021
- 资助金额:
$ 3.72万 - 项目类别:
iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities
iGLAMOUR 研究:青光眼依从性和监测代表性不足的少数群体的创新
- 批准号:
10330002 - 财政年份:2021
- 资助金额:
$ 3.72万 - 项目类别: